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Mucosal lymphoid tissues such as human tonsil are colonized by bacteria and exposed to ingested and inhaled antigens,
requiring tight regulation of immune responses. Antibody responses are regulated by follicular helper T (TFH) cells and FOXP3+
follicular regulatory T (TFR) cells. Here we describe a subset of human tonsillar follicular T cells identified by expression of
TFH markers and CD25 that are the main source of follicular T (TF) cell–derived IL-10. Despite lack of FOXP3 expression, CD25+
TF cells resemble T reg cells in high CTLA4 expression, low IL-2 production, and their ability to repress T cell proliferation. CD25+
TF cell–derived IL-10 dampens induction of B cell class-switching to IgE. In children, circulating total IgE titers were inversely
correlated with the frequencies of tonsil CD25+ TF cells and IL-10–producing TF cells but not with total T reg cells, TFR, or IL-
10–producing T cells. Thus, CD25+ TF cells emerge as a subset with unique T and B cell regulatory activities that may help
prevent atopy.
Introduction
High-affinity antibodies are critical for long-lived host defense
after infection or vaccination. Conversely, dysregulation of an-
tibody responses is the basis of both serious autoimmune dis-
eases and allergy (Vinuesa et al., 2016). It is clear that specialized
B cell lymphoma 6 protein (BCL6)–driven B helper follicular T
(TFH) cells are essential in supporting and regulating the quality
and longevity of antibody responses (Crotty, 2011; Vinuesa et al.,
2016). TFH cells first interact with antigen-specific B cells at the
borders between T cell zones and B cell follicles, driving B cells to
differentiate in extrafollicular foci as short-lived plasmablasts
(Lee et al., 2011), and then after repeated cycles of division and
mutation within germinal centers (GCs). TFH cells also drive GC
B cell differentiation into long-lived plasma cells and memory
B cells. Limiting TFH cell help appears to be crucial for long-lived
high-affinity antibody responses (Victora et al., 2010), and ab-
errant accumulation of TFH cells has been shown to promote
selection of GC B cells and lead to autoantibodies (Vinuesa et al.,
2005; Linterman et al., 2009; Simpson et al., 2010) and IgE+
B cells (Yang et al., 2016). The BCL6+ follicular T (TF) cell
population also contains regulatory cells made up of a thymic-
derived and peripherally induced forkhead box P3 (FOXP3)–
expressing population known as follicular regulatory T cells
(TFR; Chung et al., 2011; Linterman et al., 2011; Wollenberg et al.,
2011). In mice, TFR cells have been shown to repress GC B cells
and antibody responses (Sage et al., 2016). Regulatory CD25+
T cells and follicular FOXP3+ T cells have also been reported in
humans (Lim et al., 2004; Carreras et al., 2006; Chung et al.,
2011) and circulating follicular FOXP3+ regulatory populations
have been described (Fonseca et al., 2017; Wing et al., 2017).
Nevertheless, the nature of TFR cells in human tonsil, the most
accessible human secondary lymphoid tissue, remains un-
characterized. CD25+ TF cells have been reported in human
tonsils but are not considered to carry out regulatory roles based
on their lack of FOXP3 expression (Li and Pauza, 2015), even
though functional studies are lacking.
Anaphylaxis and other acute allergic reactions are growing
in incidence and are poorly understood problems causing
increasing morbidity and mortality (Yue et al., 2018). These
reactions are driven by cross-linking of IgE bound to the high-
affinity IgE receptor (FcεRI) on mast cells and basophils, which
leads to the release of inflammatory and vasoactive mediators
(Galli et al., 2008). Allergic pathology is often located at epi-
thelial and mucosal sites and consists of type 2 immune re-
sponses, in which signature cytokines IL-4 and IL-13 are derived
.............................................................................................................................................................................
1Department of Immunology and Infectious Disease and Centre for Personalised Immunology, The John Curtin School of Medical Research, The Australian National
University, Canberra, Australia; 2Department of Immunology, Canberra Hospital, Canberra, Australia; 3Laboratory of Experimental Immunology, World Premier
International Research Center Immunology Frontier Research Center, Osaka University, Osaka, Japan; 4Discipline of Pathology, School of Medical Sciences, Charles Perkins
Centre, University of Sydney, New South Wales, Australia; 5Division of Infectious Diseases and HIV Medicine, Case Western Reserve University, Cleveland, OH; 6Cytokine
Receptor Laboratory, Centre for Cancer Biology, Adelaide, Australia; 7Department of Systems Immunology and Braunschweig Integrated Centre of Systems Biology,
Helmholtz Centre for Infection Research, Braunschweig, Germany; 8Department Pathology, San Raffaele Scientific Institute, Universita` Vita-Salute, Milan, Italy.
Correspondence to Carola G. Vinuesa: carola.vinuesa@anu.edu.au.
© 2019 Cañete et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/).
Rockefeller University Press https://doi.org/10.1084/jem.20190493 1
J. Exp. Med. 2019
on July 23, 2019jem.rupress.org Downloaded from 
http://doi.org/10.1084/jem.20190493Published Online: 17 June, 2019 | Supp Info: 
from type 2 innate lymphoid (ILC2) cells, basophils, or CD4+
helper T cells (Voehringer et al., 2006; Licona-Limón et al., 2013;
Hammad and Lambrecht, 2015). These signature cytokines drive
B cells to undergo class switch recombination (CSR) to IgE.
There is evidence that IgE-producing plasma cells can arise both
upon T cell priming of B cell differentiation along the extra-
follicular route and upon interaction with T cells within epi-
thelial lesions as a result of sequential CSR in IgGmemory B cells
that arose in GCs (Erazo et al., 2007; Xiong et al., 2012; He et al.,
2013). IgE+ B cells can also be found in GCs (He et al., 2013), and
several lines of evidence have suggested that TFH cells contribute
to IgE production (Glatman Zaretsky et al., 2009; King and
Mohrs, 2009; Reinhardt et al., 2009; Coquet et al., 2015;
Ballesteros-Tato et al., 2016). Recently, a dependence of TFH cells
has been confirmed for mouse IgE responses induced by air-
borne antigens (Kobayashi et al., 2017). IgE responses appear to
be tightly regulated, particularly in the context of GC responses,
with several B cell–intrinsic mechanisms shown to limit IgE
production (Yang et al., 2012; He et al., 2013; Butt et al., 2015). To
date, despite an established role of regulatory T (T reg) cells in
IgE repression (Josefowicz et al., 2012a), whether TFR cells con-
tribute to IgE regulation remains unclear.
Here, we describe unique regulatory functions of human
tonsillar follicular CD25+ T cells, which are the main producers
of IL-10 among human TF cells. Despite exhibiting similarities to
mouse TFR cells both phenotypically and functionally, CD25+ TF
cells in tonsil are FOXP3 negative. Strikingly, these cells exert a
strong suppression on human TFH cells and expression of key
molecules BCL6, CD40L, and IL-21, while not directly sup-
pressing plasma cell differentiation of B cells. CD25+ TF cell–
derived IL-10 dampened induction of Ig switching to IgE. In
children, serum total IgE titers were inversely correlated with
the frequencies of tonsil CD25+ TF cells and IL-10–producing TF
cells, but not with total T reg cells, TFR cells, or IL-10–producing
T cells. Thus, CD25+ TF cells emerge as a subset with unique T
and B cell regulatory activities that may help prevent atopy.
Results
Identification of tonsillar CD25+ FOXP3− TF cells that express
abundant IL-10
In an effort to identify the human equivalent of mouse TFR cells,
we stained cells from the most accessible human secondary
lymphoid tissue, tonsil, for markers of TF cells and T reg cells.
Total T reg cells were identified by expression of CD25 in the
absence of CD127 (Seddiki et al., 2006; Fig. 1 a). The majority of
CD25+ CD127− T reg cells found within the nonfollicular T ef-
fector gate (C-X-C motif chemokine receptor 5 [CXCR5]int and
programmed cell death protein 1 [PD-1]int) expressed FOXP3,
and as such constitute the conventional T reg cell population
(Fig. 1, a and b). A CD25+ CD127− subset was also identified
within the follicular CXCR5hi PD-1hi population, which we refer
to as “CD25+ TF” cells (Fig. 1 a). We speculated that these might
correspond to the TFR cell population identified in mice. To our
surprise, the majority (∼95%) of these tonsillar CD25+ CD127− TF
cells lacked FOXP3 expression (P < 0.0001; Fig. 1 b). We also
identified follicular CD25+ FOXP3+ and CD25− FOXP3+ T cells
(Fig. S3 a). CD25+ FOXP3− TF cells were also present in human
mesenteric lymph nodes, although these were less frequent than
those seen in the tonsil and found at proportions comparable to
CD25+ FOXP3+ T cells (P = 0.2236; Fig. S1).
We were intrigued by the lack of FOXP3 expression among
the majority of CD25+ TF cells and considered that CD25 ex-
pression may be either identifying activated TFH cells or a T reg
cell subset independent of FOXP3 expression. FOXP3-negative T
reg cells have been described in humans and mice, and among
these are type 1 regulatory (Tr1) cells that produce IL-10 and are
identified by expression of the lymphocyte activating gene 3
(LAG3; Gagliani et al., 2013). We therefore investigated the rel-
ative ability of the different tonsil T cell subsets to produce IL-10.
Strikingly, staining for IL-10 revealed that the FOXP3− CD25+ TF
cell population was the subset containing the largest fraction of
IL-10–producing T cells in human tonsil (Fig. 1 c): 20–30% ex-
pressed IL-10 compared with 3–12% of conventional T reg cells
(P < 0.0001) and barely any TFH cells (P < 0.0001; Fig. 1 c). Unlike
IL-10–producing Tr1 cells, IL-10–producing TF cells did not ex-
press LAG3 (Fig. 1 d), suggesting that CD25+ TF cells may not be
Tr1 cells with a follicular phenotype.
Having demonstrated that only a fraction of CD25+ TF cells
expressed IL-10, we asked whether IL-10+ and IL-10− TF cells
were fundamentally different subsets. Transcriptional profiling
using Affymetrix RNA microarrays of IL-10–producing versus
nonproducing TF cells revealed highly comparable tran-
scriptomes (Fig. 2 a), with only a few differentially expressed
transcripts including IL-10, C-C motif chemokine 4-like
(CCL4L2), T-lymphocyte maturation-associated protein (MAL),
microRNA424 (MIR424; reported to be an activator of TGF-β
signaling; Li et al., 2014), lymphoid enhancer binding factor
1 (LEF1; a transcription factor important for TFH differentiation;
Choi et al., 2015), and the surface receptor cell adhesion mole-
cule 1 (CADM1), which has been previously reported to mark a
population of adult T cell leukemia/lymphoma (Komohara et al.,
2017). To evaluate whether CADM1 expression could identify the
IL-10–producing CD25+ TF cells, we stained human tonsils with
an anti-CADM1 antibody together with TF- and T reg cell–
specific markers. While CADM1 expression failed to detect all
IL-10–producing cells within the CD25+ TF population (Fig. 2 b,
upper panels), it did exclude most FOXP3-expressing TF cells
(Fig. 2 b, lower panels). Altogether, these results suggest that IL-
10–producing and nonproducing CD25+ TF cells are closely re-
lated, with IL-10 probably being produced upon CD25+ TF cell
activation.
CD25+ TF cells suppress T cell proliferation
To investigate whether CD25+ TF cells were simply activated TFH
cells that had up-regulated CD25, as previously proposed (Li and
Pauza, 2015) and as opposed to T reg cells, we tested their ability
to suppress T cell proliferation in vitro. Unlike typical TFH cells
(CD25− CD127−), human CD25+ TF cells and T reg cells were
equally effective in suppressing conventional (CD25− CD4+)
T cell proliferation (Fig. 2 c), as previously described for mouse
TFR cells (Chung et al., 2011; Linterman et al., 2011). While it is
unlikely that the small contaminating number of FOXP3+ cells
among tonsillar CD25+ TF cells (i.e., the equivalent to mouse TFR
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cells) is responsible for the overall suppressive effect of this
population in the cell titration response, we sought to exclude
the contribution from such TFR cells. We used CADM1 to sort
FOXP3− CD25+ TF cells. CADM1+ and CADM1− TF cells suppressed
T cell proliferation as effectively as T reg cells (Fig. 2 d), dem-
onstrating that CD25+ TF cells exert T reg cell functions even in
the absence of FOXP3 expression. Given that CADM1 does not
distinguish IL-10+ versus IL-10− CD25 TF cells, it is unlikely that
IL-10 mediates suppression of T cell proliferation. Indeed, IL-10
blockade in these cultures did not affect this regulatory property
of CD25+ TF cells (data not shown). Altogether, these results
suggest that human CD25+ CD127− TF cells are not simply acti-
vated TFH cells, but can behave like T reg cells.
To gain insights into the ontogeny of CD25+ TF cells, and
specifically ask whether these cells may have expressed FOXP3
as thymic T reg cells (tT reg cells) and later down-regulated it,
we investigated the methylation of the conserved noncoding
sequence 2 (CNS2) locus of the FOXP3 promoter. Demethylation
of this locus is critical for the stable FOXP3 expression that
characterizes tT reg cells; Zheng et al., 2010). The CNS2 locus
was >90% methylated in human CD25+ TF cells (Fig. 3 a), sug-
gesting a peripheral rather than thymic origin. Similarly, com-
pared with conventional nonfollicular T reg cells, CD25+ TF cells
expressed 40% less HELIOS (Fig. 3 b, P = 0.0002), a known
target of FOXP3 (Fu et al., 2012) that is abundant in, although not
exclusive of, tT reg cells (Thornton et al., 2010; Szurek et al.,
2015). Together, these data demonstrate the existence of human
CD25+ FOXP3− TFR cells that are unlikely to originate from tT reg
cells and appear to be enriched in tonsillar tissue.
Figure 1. Identification of IL-10–producing
CD25+ FOXP3− human TF cells in human ton-
sils. (a) Flow cytometric plots showing gating
strategy to identify the indicated populations.
(b) Flow cytometric plots and quantification (n =
8) showing percentage of FOXP3+ cells and
FOXP3 mean fluorescence intensity (MFI) within
the indicated subset according to panel a. Data
are representative of 10 independent experi-
ments. (c) Flow cytometric plots and quantifi-
cation of PMA/ionomycin-stimulated tonsillar
cell suspensions showing IL-10 expression in the
indicated subset (n = 9). Data are representative
of 10 experiments. (d) Flow cytometric plots and
quantification showing LAG3 and CD25 expres-
sion in total TF cells (n = 14; left), and IL-10 and
LAG3 in CD25+ TF cells (n = 5; right). Data are
representative of five independent experiments.
In all graphs, bars represent medians, and each
dot represents a single tonsil donor. ****, P ≤
0.0001, nonparametric Mann–Whitney U test.
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Figure 2. Human CD25+ TF cells repress T cell proliferation. (a) Volcano plot showing Affymetrix RNA microarrays comparing gene expression between IL-
10–producing and nonproducing TF cells (n = 3). (b) Flow cytometric plots showing coexpression of CADM1 with IL-10 or FOXP3 in PMA/ionomycin-stimulated
tonsillar cell suspensions in the indicated subset (n = 5). Data are representative of two independent experiments. (c and d) Flow cytometric plots and
quantification of proliferating CD4+CD25− responder T cells according to dilution of the cytoplasmic fluorescent dye CTV after 3 d of α-CD3 and α-CD28
stimulation in the presence or absence of T reg cells (n = 10), CD25+ TF cells (n = 8), and CD25− TFH cells (n = 5; c) or T reg cells (n = 3), CADM1+CD25+ TF cells
(n = 3), and CADM1−CD25− T cells (n = 3; d). Bars represent medians, and each dot represents the mean value of cultures set up in triplicate from a single donor.
Data are representative of five (c) and two (b and d) independent experiments. ns, not significant; **, P ≤ 0.01; ***, P ≤ 0.001, nonparametric Mann–Whitney U
test (c, left panel) and two-way ANOVA (c, right panel, and d).
Cañete et al. Journal of Experimental Medicine 4
Human CD25+ TF cells control IgE responses https://doi.org/10.1084/jem.20190493
We next investigated whether, in spite of absent FOXP3 ex-
pression, CD25+ TF cells display the two key characteristics of
conventional T reg cells known to be crucial for their suppressor
function: high cytotoxic T lymphocyte–associated protein 4
(CTLA4) expression and low IL-2 production. CTLA4 is one of
the most important targets of FOXP3 in T reg cells, and high
amounts of CTLA4 expression plus absence of IL-2 production is
a good marker of T reg cell function even in the absence of
FOXP3 expression (Yamaguchi et al., 2013). We found that
CD25+ TF cells had the highest amount of CTLA4 among tonsil
Figure 3. Human CD25+ TF cells may be peripherally induced and express high CTLA4 but low IL-2 production. (a) Bisulfite sequencing of the 11 CpG
islands of the FOXP3 CNS2 locus with 12 representative clones per population and per donor (filled circle, methylated; open circle, demethylated). (b) Flow
cytometric plots and quantification showing HELIOS expression in the indicated cell subsets (n = 8). Data are representative of three independent experiments.
(c) Flow cytometric plots and quantification (n = 8) showing CTLA4 expression in the indicated cell subset. Data are representative of five independent
experiments. (d and e) Flow cytometric plots and quantification showing gating strategy (d) and IL-2 expression of PMA/ionomycin-stimulated tonsillar cell
suspensions in the indicated subset (n = 8; e). Data are representative of two independent experiments. In all graphs, bars represent medians, and each dot
represents a single donor. **, P ≤ 0.01; ***, P ≤ 0.001, nonparametric Mann–Whitney U test. FSCA, forward scatter.
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T cell subsets (Fig. 3 c), and IL-2 production was detected in only
∼5% of human tonsil CD25+ TF cells (Fig. 3, d and e). These re-
sults further suggest that CD25+ TF cells are indeed a T reg cell
subset.
Human CD25+ TF cells resemble mouse TFR cells
To investigate the extent to which human CD25+ TF cells re-
semble mouse TFR cells, we obtained the transcriptional signa-
ture of CD25+ TF cells. As shown before, we noted that among TF
cells, CD25+ TF cells did not overlap with LAG3+ TF cells. Thus,
we FACS-purified naive T cells and the three major TF cell
subsets according to CD25 and LAG3 expression, CD25+ LAG3− TF
cells, CD25− LAG3+ TF cells, and CD25− LAG3− TFH cells (Fig. 4 a),
and performed RNA sequencing (RNA-seq). Paired analyses
from three different tonsil donors revealed that CD25+ TF cells
were fundamentally different from naive, TFH, and LAG3+ TFH
cells (Fig. 4 b) and were remarkably similar to the phenotype
described for mouse TFR cells (FOXP3+ TF cells). Indeed, human
CD25+ TF cells expressed key molecules required for TFH de-
velopment, including BCL6, and showed the highest expression
of transcripts associated with effector T reg cells including
CTLA4, glucocorticoid-induced TNFR-related protein (GITR), PR
domain zinc finger protein 1 (PRDM1), Runt-related transcrip-
tion factor 2 (RUNX2), C-C chemokine receptor type 5 (CCR5),
and IL-10 (Fig. 4 c; Fu et al., 2012). Similar to mouse TFR cells,
human CD25+ TF cells expressed the lowest amount of the key
B cell helper molecule CD40L but abundant IL-21 transcript and
protein (Fig. S2, a and b), which is low inmouse TFR cells but has
also been shown to be expressed in TFR cells from macaques
(Chowdhury et al., 2015).
Flow cytometric analysis of protein expression validated our
transcriptomic analyses and confirmed the similarities between
CD25+ TF cells and T reg cells (Fig. 4 d). Also, minimal differences
were observed between the small fraction of tonsil follicular
FOXP3+ CD25+ and the more abundant FOXP3− CD25+ TF cells.
The latter expressedmore IL-10 and BCL6, whereas FOXP3+ cells
expressed more HELIOS and GITR (both direct targets of FOXP3;
Fig. S3). Together, these results suggest that human CD25+ TF
cells have a gene expression profile that allows migration to
facilitate T:B cell encounters and T reg cell function as well as
abundant expression of IL-10.
Human CD25+ TF cells regulate TFH cells and B cell IgE
production
Inmice, both B and TFH cells have been suggested to be targets of
TFR cell suppression (Sage and Sharpe, 2016). To test whether
CD25+ TF cells could regulate TFH cell function, we analyzed TFH
cells after 3 d in culture with autologous memory B cells and
CD25+ TF cells in the presence of Staphylococcus enterotoxin B
(SEB). Addition of CD25+ TF cells suppressed TFH cell prolifera-
tion (Fig. 5 a). In addition, we observed that CD25+ TF:TFH co-
cultures reduced the percentage of CD40L-expressing TFH cells
(P < 0.0001) and also reduced CD40L expression per TFH cell by
50% (P < 0.0001; Fig. 5 b), as well as IL-21 production (P <
0.0001) and BCL6 expression (P = 0.0010; Fig. 5 b). Reduction of
each of these TFH cell molecules is known to limit TFH cell help
for B cells (Vinuesa et al., 2016). Similar results were obtained in
cultures in which B cells were not included and TFH cells were
activated with αCD3/αCD28 antibodies (Fig. 5 c), suggesting that
CD25+ TF cells act directly on TFH cells to suppress their function.
These regulatory effects were not IL-10 mediated, as addition of
an IL-10 blocking antibody did not rescue CD25+ TF cell–
mediated repression of TFH cell proliferation or expression of
CD40L, IL-21, or BCL6 (Fig. S4 a).
Next, we compared the ability of human TFH and CD25+ TF
cells to induce B cell responses. Human memory B cells were
cocultured with autologous TFH or CD25+ TF cells for 7 d in the
presence of SEB. Coculture of B cells with TFH cells successfully
induced cell division, differentiation of plasma cells (Fig. 5 d),
and secretion of IgG and IgE (Fig. 5 e). Coculture with CD25+ TF
cells induced plasma cell differentiation, although to a lesser
extent (Fig. 5 d, left), and modest B cell proliferation (Fig. 5 d,
right) and resulted in a 5.2-fold decrease in IgE secretion and a
2.7-fold decrease in IgG compared with TFH cocultures (Fig. 5 e).
Addition of TFH cells to the CD25+ TF:B cell cocultures at equal
ratios rescued plasma cell production, B cell proliferation, and
IgG production, but not IgE production (Fig. 5, d and e). To-
gether, these data suggest that human CD25+ TF cells are able to
regulate TFH cell function and B cell IgE production.
Human CD25+ TF cell–derived IL-10 represses epsilon germline
transcription
Early reports from human in vitro studies showed that IL-10
could suppress class-switching to IgE but not IgG (Jeannin et al.,
1998; Akdis and Blaser, 2001). Since IL-10 can have additional
effects on B cells such as promoting plasma cell differentiation
(Arpin et al., 1995), we sought to separate the observed action of
CD25+ TF cells on plasma cell induction (Fig. 5 d) from possible
repressive effects on Ig switching to IgE by looking at the earliest
event that occurs in cells undergoing CSR: production of germ-
line transcripts (GLTs). To investigate direct CSR events to IgE
from IgM+ B cells as opposed to sequential CSR, in which an
initial IgM-to-IgG1 CSR event is followed by switching to IgE, we
limited our culture to 25 h. This is sufficient to induce the
production of εGLTs, but is not sufficient for naive B cells to
undergo two cell divisions, thus preventing sequential CSR from
occurring (Erazo et al., 2007). Naive CD19+ IgD+ human B cells
were purified and cocultured with TFH cells and stimulated with
IL-4, IL-13, and SEB in the presence or absence of CD25+ TF cells.
Although addition of CD25+ TF cells did not have a statistically
significant effect on γGLT induction, it consistently reduced
εGLTs in TFH:B cell cocultures (Fig. 5 f). While there was high
variability across individuals, paired statistics revealed a re-
duction in εGLT across 18 human donors (P = 0.0006). CD25+ TF
cells repressed εGLTs in IgM+ but not in IgG+ memory B cells
(Fig. S4 b), suggesting that CD25+ TF cells preferentially repress
direct as opposed to sequential induction of CSR to IgE, or that
CD25+ TF cells preferentially interact with IgM+ B cells (naive or
memory).
IL-10 has been shown to suppress εGLTs in human B cell
cultures (Jeannin et al., 1998). We therefore evaluated the con-
tribution of IL-10 to CD25+ TF cell–mediated suppression of
εGLTs. Blocking the IL-10 receptor (Fig. S4 c) did not have a
profound effect on γGLT but rescued εGLTs in CD25+ TF:B cell
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cocultures (Fig. 5 g) in 8 out of 10 donors. Taken together, these
data suggest that IL-10 contributes to suppression of IgE pro-
duction by human CD25+ TF cells.
IL-10–producing CD25+ TF cells inversely correlate with
circulating IgE in the serum
To gain some insights into the possible clinical relevance of
CD25+ TF cells, we collected blood from pediatric tonsil donors at
the time of tonsillectomy and produced a cohort of matched
serum and tonsil samples from 50 individuals. We then inves-
tigated associations between total IgE in serum and CD25+ TF
cells in tonsils. Strikingly, we observed an inverse correlation
between the frequency of CD25+ TF cells, measured as either a
percentage of T reg cells or of CD4+ T cells, and the amount of IgE
in serum (Fig. 6 a). The more frequent CD25+ TF cells were, the
less abundant total IgE in serum, suggesting that CD25+ TF cells
may indeed regulate IgE production. Although the goodness of
fit in this model was somewhat weak (r = 0.5107), the deviation
from zero in the correlation was highly significant, demon-
strating a negative correlation between the two variables. Sim-
ilar results were obtained when we correlated the amount of
total IgE and the frequency of IL-10–producing TF cells (Fig. 6 a).
Compared with CD25+ TF cells that lack FOXP3 expression, no
negative correlation was observed between serum IgE and the
Figure 4. Human CD25+ TF cells’ transcriptome resembles that of murine TFR cells. (a) Flow cytometric plots showing the gating strategy used to FACS-
purify each of the indicated cell subsets. (b) Heatmap analysis of RNA-seq data showing differentially expressed genes in CD25+ TF cells compared with the
indicated T cell populations (log2 value of counts per million) extracted from the tonsils of three individuals. (c) Selected transcripts from panel b in the
indicated subsets (RNA counts per million [CPM]). (d) Flow cytometric plots and quantification (n = 8) of the indicated proteins. Data are representative of at
least three independent experiments. In all graphs, bars represent medians; each dot represents a single tonsil donor. ***, P ≤ 0.001, nonparametric
Mann–Whitney U test.
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Figure 5. Human CD25+ TF cells repress TFH cells and induction of IgE switching. (a and b) Flow cytometric plots (a) and quantification (n = 8; b) of CTV-
labeled-TFH cells, cocultured with memory B cells with or without CD25+ TF cells, showing expression of the indicated proteins after 3 d. Upper panels are
representative data for a single donor, and lower panels are pooled values from different donors and experiments. Data in each panel is representative of at
least five independent experiments. (c) Flow cytometric plots and quantification of CTV-labeled TFH cells, cocultured with or without CD25+ TF cells, showing
expression of the indicated proteins after 3 d of α-CD3 and α-CD28 stimulation. (d) Quantification of plasma cell (CD27+ CD38+) differentiation (n = 25) or
proliferation (n = 12) from memory B cells cocultured with TFH cells, CD25+ TF cells, or both in the presence of SEB (500 ng/ml), IL-4, and IL-13 (40 ng/ml) for
7 d. (e) IgG (n = 10) or IgE (n = 14) in coculture supernatants of cocultures as in panel d. Data were normalized to values from cultures without T cells. Data in d
and e were pooled from eight independent experiments. (f and g)Quantification of γGLTs (top) or εGLTs via qPCR in naive B cells incubated with TFH cells with
or without CD25+ TF cells (n = 19; f), and naive B cells cocultured with CD25+ TF cells in the presence or absence of an IL-10 blocking antibody (n = 10; g). GLT
expression values were calculated using the ΔΔCT method and were normalized to RPL13A levels, then normalized to the untreated control. Data were pooled
from five independent experiments. Bars represent means of three technical replicates (b and c) or medians (d–g), each dot represents a single tonsil donor,
and error bars represent standard deviations. ns, not significant; *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001, two-tailed Student’s t test (b, top
panels, and c–g) and nonparametric paired Wilcoxon test (b, bottom panels). All data are representative of at least three independent experiments. MFI, mean
fluorescence intensity; RU, relative units.
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frequency of FOXP3+ TFR cells; in fact, a positive correlation was
seen (Fig. 6 b, left). No correlations were detected between se-
rum IgE and total T reg cells or even total IL-10–producing CD4+
T cells (Fig. 6 b, right), suggesting that CD25+ TF cells are the cells
specialized in preventing unwanted IgE production.
Given that IL-10 has been reported to cooperate with IL-4 in
inducing B cell production of IgG4, and that the latter correlates
with allergy desensitization and tolerance, we asked whether
CD25+ TF cells could also regulate IgG4 responses (Akdis and
Akdis, 2014). Pearson correlation analysis revealed no relation-
ship between circulating IgG4 and the frequency of CD25+ TF
cells or IL-10–producing TF cells (Fig. S5 a). A positive correla-
tion was observed between the frequency of T reg cells and IgG4
(Fig. S5 b), possibly suggesting a division of labor between T reg
cells and CD25+ TF cells in promoting tolerogenic IgG4 versus
repressing IgE responses.
Finally, we asked whether the frequency of CD25+ TF cells
differed between those donors who exhibited high amounts of
IgE versus those with low titers. The clinical value for normal
total IgE in children ranges from 2 to 200 IU, or 2.4 to 480 ng/ml
(Martins et al., 2014). An average of total serum IgE in healthy
individuals of 100 ng/ml has been reported (Gould, 1998) and
was the average value found in our tonsil/serum cohort
(Fig. 6 c). We selected 100 ng/ml as a cutoff to separate tonsil
donors with high versus low IgE titers and thus interrogated
whether the frequency of CD25+ TF cells differed in both groups.
CD25+ TF cells, as a percentage of T reg cells or CD4 T cells, were
significantly less frequent in donors with high IgE titers (62%
and 42% median decrease, respectively; Fig. 6 d). Similarly, the
frequency of IL-10–producing TF cells was more abundant in
donors with low IgE titers. Altogether, these results show an
inverse correlation between CD25+ TF cells and serum IgE,
suggesting that CD25+ TF cells are physiological regulators of IgE
production.
Discussion
Here we have described a novel regulatory function of a unique
human TF cell subset that is abundant in tonsil, CD25+ TF cells,
and is the major IL-10–producing subset among TF cells. CD25+
TF cells are identified by high expression of the GC TFH cell
markers PD-1 and CXCR5 together with T reg cell markers
Figure 6. Tonsillar CD25+ TF cells inversely
correlate to total IgE in the serum. (a and b)
Pearson correlation analyses between serum
total IgE and the frequency of the indicated cell
subset in tonsil (n = 49). Data are representative
of two independent experiments that were
pooled together. (c) Histogram showing the
frequency distribution of serum total IgE (log10
ng/ml) from 49 children (mean = 2.07).
(d) Quantification of the frequency of the indi-
cated cell subset from tonsil donors with high
(>100 ng/ml) or low (<100 ng/ml) total serum
IgE titers. Bars represent medians, and dots
represent individual tonsil donors (n = 49). Data
are representative of two independent experi-
ments that were pooled together. ***, P ≤ 0.001;
****, P ≤ 0.0001, nonparametric Mann–Whitney
test U test.
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(CD25hi CD127lo CTLA4hi IL-2lo) and high IL-10 production in the
absence of FOXP3 expression. Several lines of evidence indicate
that this subset is functionally related to FOXP3-expressing T
reg cells. First, our transcriptomic and proteomic characteriza-
tion of CD25+ TF cells has revealed that they closely resemble
mouse TFR cells, except for the absence of FOXP3 expression and
IL-21 production. A CD25+ nonfollicular T reg cell population
that also lacks FOXP3 expression and produces IL-10 has been
previously described (Facciotti et al., 2016). These cells regulate
B cell responses and, when dysregulated, are associated with
autoimmune diseases. Second, besides high CTLA4 expression,
CD25+ TF cells express low levels of IL-2. These observations are
consistent with previous evidence that T cells engineered to
express CTLA4 and not IL-2 adopt full T reg cell–like activity
even in the absence of FOXP3 (Yamaguchi et al., 2013). Absence
of demethylation in the FOXP3 CNS2 promoter, together with
low HELIOS expression, suggests that this subset may be in-
duced in the periphery, arising from conventional naive CD4+
T cells or from TFH cells themselves.
Functionally, we show that human CD25+ TF cells exert
suppressive effects on both T and B cells. With respect to T cells,
CD25+ TF cells repress total T cell and TFH cell proliferation and
function. CD25+ TF cells dampen TFH cell help through direct
down-regulation of CD40L, IL-21, and BCL6 on TFH cells. CD25+
TF cells also exert regulatory effects on B cells. First, CD25+ TF
cells appear to dampen B cell CSR to IgE. The latter occurs in an
IL-10–dependent manner. Indeed, CD25+ TF cells reduce εGLT
production in TFH:B cell cocultures, and this effect is rescued by
IL-10 blockade. This is interesting, because IL-10 acts very early,
within 25 h of naive (unswitched) B cell activation, to suppress
CSR by inhibiting εGLT production. Our experimental system
shows this effect is a direct consequence of limiting direct CSR
from μ to ε, rather than inhibiting γGLT production and sub-
sequent sequential class-switching. It is still unclear whether
CD25+ TF cells predominantly target naive, GC B, or memory
B cells in vivo. TFH cells influence B cell activation at multiple
stages, from the earliest B cell priming stages at the T:B border
where Ig CSR is initially triggered (Jacob et al., 1991; Toellner
et al., 1996), to selection in GCs, and reactivation as memory
B cells (Vinuesa et al., 2016). Thus, CD25+ TF cells are also likely
to interact with and influence naive and memory B cell isotype
switching.
Interestingly, and as shown for mouse IL-10–producing TF
cells, CD25+ TF cells induced some plasma cell differentiation,
although to a lesser extent than TFH cells. This contrasts with
mouse TFR cells that effectively repress B cell differentiation
(Sage et al., 2016; Botta et al., 2017; Maceiras et al., 2017). One
obvious difference between mouse (FOXP3+) TFR cells and the
human tonsillar FOXP3− CD25+ TF cells described here is the
production of IL-21 by the latter but not the former. IL-21 is
known to promote plasma cell differentiation in mice (Ozaki
et al., 2002) and humans (Ettinger et al., 2005), so it is possi-
ble that this cytokine contributes to plasma cell differentiation,
potentially in conjunction with CD25+ TF cell–derived IL-10.
Although we could not see effects of IL-10R blockade on plasma
cell differentiation in 7-d cultures (unpublished data), it is pos-
sible that the conditions were not optimal for durable IL-10
blockade in these assays. Interestingly, unlike in mice, in which
IL-21 inhibits IgE formation (Ozaki et al., 2002), IL-21 is a potent
inducer of IgE in CD40L-stimulated human B cells (Berglund
et al., 2013). Thus, there appears to be dissociation between
the effects of CD25+ TF cells on plasma cell formation, possibly
conferred by IL-21 with or without contribution of IL-10, and
CSR conferred by IL-10. CD25+ TF cells emerge as a unique
regulatory cell that controls switching independently of B cell
differentiation.
Thymus-derived T reg cells that stably express FOXP3 are
selected on the basis of their ability to recognize self-antigen in
the thymus (Hsieh et al., 2012). T reg cells give rise to TFR cells in
immunized mice (Chung et al., 2011; Linterman et al., 2011;
Wollenberg et al., 2011; Sage et al., 2014; Wing et al., 2014;
Aloulou et al., 2016), making them effective suppressors of re-
sponses against self. Recent reports have also suggested mouse
TFR cells can be induced in the periphery in responses to both
self and foreign antigens (Aloulou et al., 2016). The human
CD25+ TF cells described in this study lack FOXP3 expression and
appear not to be thymus derived. The fact that CD25+ TF cells are
so abundant in tonsils, which are exposed to oral and inhaled
antigens, but are scarce in other lymphoid tissues that are not
exposed to such antigens, makes them particularly good candi-
dates to suppress responses to harmless foreign antigens. Fur-
thermore, our observation that CD25+ TF cells repress CSR to IgE
and are associated with lower circulating IgE titers in children
undergoing tonsillectomy suggests that this subset may be im-
portant to prevent IgE-mediated allergic reactions to inhaled or
ingested antigens.
Besides a role in preventing immune responses and proal-
lergenic IgE to innocuous antigens, the chronic and ongoing
nature of GC reactions in human tonsils makes this subset highly
suitable to control excessive and harmful inflammation to for-
eign antigens, thus serving as a natural homeostatic mechanism
to curtail TFH cell responses. Equivalent T reg cell subsets have
been described that are specialized in repressing TH2 and TH1
lineages (Jankovic et al., 2007; Altin et al., 2012; Josefowicz et al.,
2012b). There is evidence that TFR cells can be induced against
both self and foreign antigens (Aloulou et al., 2016), but it re-
mains unclear whether self- or innocuous environmental anti-
gens such as allergens aremore conducive to TFR or CD25+ TF cell
development.
In summary, our work unveils a novel subset of TFR cells in
humans, characterized by abundant production of IL-10, which
regulates several aspects of T and B cell responses and prevents
induction of switching to IgE. Importantly, low numbers of
CD25+ TF cells are associated with elevated circulating IgE levels.
We therefore predict that deficiencies in homeostasis or func-
tion of this cell subset could underpin susceptibility to allergic
and anaphylactic reactions induced by inhaled and ingested
antigens. Should this be the case, these findings may open up
new avenues for boosting CD25+ TF cells to reduce the risk of
allergy.
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Materials and methods
Human tonsil and lymph node cells
Human tonsils were obtained from children undergoing rou-
tine tonsillectomy. Tonsillar lymphocyte single-cell suspen-
sions were prepared by mechanical disruption of the tissue
followed by cell separation using Ficoll-Hypaque (GE Health-
care Life Sciences) gradient and frozen until further use,
except for RNA-seq, for which fresh samples were used.
Human mesenteric lymph nodes were obtained as discarded
tissue from nonmalignancy gastrointestinal surgery. Informed
consent was obtained from all subjects. All experiments with
human samples were approved by the Australian National
University’s Human Experimentation Ethics Committee and
the Australian Capital Territory Health Human Research Ethics
Committee.
Flow cytometry
Tonsillar lymphocytes were stained with the following anti-
human antibodies: anti-CADM1 biotin (3E1; MBL), anti-CD4
APCCy7 (RPA-T4; BD Biosciences), anti-CD8 FITC (RPA-T8;
BD Biosciences) or PE (SK1; BD Biosciences), anti-CD19 FITC
(SJ25C1; BioLegend) or PE Cy7 (SJ25C1; BD Biosciences), anti-
CXCR5 Alexa Fluor 488 or 647 or PerCPCy5.5 (RF8B2; BD Bio-
sciences) or PerCP/Cy5.5 (J252D4; BioLegend), anti-CD45 RA
(HI100; BioLegend), anti-CD45RO (UCHL1; BioLegend),
anti–CTLA-4 PE (BNI3; BD Biosciences) or PE Cy7 (L3D10;
BioLegend), anti–PD-1 PE (MIH4; eBioscience) or BV605 or
BV421 (EH12.2H7; BioLegend) or unconjugated (J105; eBio-
science), anti-CD127 FITC (11-1278; eBioscience) or BV421
(A019D5; BioLegend), anti-CD25 biotin (BC96; eBioscience or
BioLegend) or PE-Cy7 (BC96; BD Biosciences or BioLegend) or
APC (2A3; BD Biosciences), anti-CD127 FITC (A019D5; eBio-
science) or BV421 (A109D5; BioLegend) or BV510 (HIL-7R-M21;
BD Biosciences), anti-FOXP3 Alexa Fluor 647 (259D; eBio-
science), anti-GITR PE (110416; R&D Systems), anti–CTLA-4
PE-CF-594 (BNI3; BD Biosciences) or PE Cy7 (L3D10; Bio-
Legend), anti-CD40L Pacific Blue or FITC (24-31; BioLegend),
anti-BCL6 Alexa Fluor 647 or PE-Cy7 (K112-91; BD Bio-
sciences), anti–BLIMP-1 Alexa Fluor 647 (646702; R&D Sys-
tems), anti-CXCL13 APC (53610; R&D Systems), anti-Helios
PE (22F6; BioLegend), anti–IL-10 PE (JES3-19F1; BioLegend)
or APC (JES3-19F1; BD Biosciences), anti–IL-10R PE (3F9; iCyt),
anti–IL-21 PE (3A3-N21; BD Biosciences), anti-IL2 Alexa Fluor
488 (MQ1-17H12; BioLegend), anti-CD3 APC (HIT3a; BD Bio-
sciences) or Alexa Fluor 700 (UCHT1; BD Biosciences) or Pa-
cific Blue (OKT3; BioLegend) or BV510 (OKT3; BioLegend),
anti-CD27 FITC or APC (M-T271; BD Biosciences), anti-CD38
FITC (HIT2; BD Biosciences) or PE (HB7; BD Biosciences),
anti-LAG3 PE or FITC (2319-L3-050; R&D Systems), and
anti-pSTAT3 Alexa Fluor 647 (4/P-STAT3; BD Biosciences).
Intracellular staining was performed using the FOXP3/Tran-
scription Factor Staining Buffer Set (eBioscience) or Cytofix/
Cytoperm (BD Biosciences) according to the manufacturer’s
instructions. LAG3 was stained at 37°C for 15 min in the
dark.
Mesenteric lymph nodes were stained with the follow-
ing anti-human antibodies: anti-CD3 BUV395 (UCHT1; BD
Biosciences), anti-CD4 PerCP (RPA-T4; BioLegend), anti-CD8
APC-C7 (RPA-T8; BioLegend), anti-CD19 APC-Cy7 (HIB19; Bio-
Legend), anti-CD45RA PE-TR (MEM-56; Invitrogen), anti-CXCR5
BV510 (RF8B2; BD Biosciences), anti–PD-1 BV421 (EH12.2H7;
BioLegend), anti-CD127 BV650 (HIL-7R-M21; BD Biosciences),
anti-CD25 PE-C7 (BC96; BioLegend), anti-FOXP3 PE (259D/C7; BD
Biosciences), and anti-CD27 BV711 (L128; BD Biosciences). Intra-
cellular staining was performed using the FOXP3/Transcription
Factor Staining Buffer Set according to the manufacturer’s
instructions.
CpG methylation analysis by bisulfite sequencing
Genomic DNA was prepared using the NucleoSpin Tissue XS kit
(Macherey-Nagel). After sodium bisulfite treatment (Methyl-
Easy Xceed, Human Genetic Signatures), modified DNA was
amplified by PCR and subcloned into PCR2.1-TOPO Vector (In-
vitrogen). PCR primers used were 59-TTGGGTTAAGTTTGTTGT
AGGATAG-39 and 59-ATCTAAACCCTATTATCACAACCCC-39.
The colonies (16–48 colonies/region) were directly amplified
using the Illustra TempliPhi Amplification Kit (GE Healthcare)
and sequenced.
In vitro stimulation
Intracellular cytokine staining was performed following 4–6 h of
PMA (50 ng/ml) and ionomycin (500 ng/ml) stimulation with
GolgiStop (BD Biosciences) or Brefeldin A (BioLegend) in RPMI
1640 medium supplemented with 10% FCS, 2 mM L-glutamine,
100 U penicillin-streptomycin, 0.1 mM nonessential amino ac-
ids, 100 mM Hepes, and 44 µM 2-mercaptoethanol. 200,000
naive B cells were FACS-purified and stimulated with 50 ng/ml
recombinant human IL-10 (Peprotech) for 30 min with or
without 5 µg/ml of anti–IL-10 blocking antibody (3F9;
BioLegend).
Secreted cytokine surface capture
Live CD4+ human tonsillar lymphocytes were stained with the
anti-human IL-10 catch reagent (Miltenyi) at 9 million cells per
100 µl. After 10 min on ice, the cells were diluted 1:20 in RPMI
supplemented as above. Cells were stimulated with PMA
(100 ng/ml) and ionomycin (500 ng/ml) and incubated for 2 h in
a 37°C incubator with 5% CO2, rotating slowly using a MacsMix
(Miltenyi). Cells were then stained as above using the anti-
human IL-10 detection antibody (Miltenyi).
Microarray RNA analysis
IL-10–positive and –negative CD25+ TF cells were FACS-purified
from three human subjects. mRNA was extracted, and samples
were sent to the Ramaciotti Centre for Genomics (Sydney,
Australia) for analysis with Affymetrix GeneChip Human Gene
2.0 ST microarrays. The resulting nine CEL files were imported
into Partek Genomics Suite (version 6.6) using the RMA algo-
rithmwith RMA background correction, quantile normalization,
and median polish probe set summarization. Differentially ex-
pressed probe sets were identified in Partek GS using a two-
factor ANOVA model with the factor SubjectID. The data are
deposited under the National Center for Biotechnology Infor-
mation Gene Expression Omnibus accession no. GSE79887.
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Autologous human tonsillar TFH:B cell cocultures and
IgE detection
20,000 human FACS-purified TFH and/or CD25+ TF cells were
cocultured with 100,000 GC B (CD4− CD19+ CD38+ CD27int) cells
or memory B (CD4− CD19+ CD38− CD27+) cells in the presence of
SEB (500 ng/ml; Sigma-Aldrich) for 3, 5, or 7 d. For IgE-inducing
conditions, recombinant IL-4 and IL-13 (Peprotech) were used at
40 ng/ml. Culture supernatants, or human serum, were used to
measure IgE, IgG, and IgG4 using the Cytometric Bead Array flex
sets (558682, 558679, and 558678; BD Bioscience) according to
the manufacturer’s instructions. For proliferation assays, cells
were stained with CellTrace Violet (CTV; Thermo Fisher Sci-
entific) according to manufacturer’s instructions. IL-10R block-
ade was achieved using anti–IL-10R blocking antibody (3F9;
BioLegend) or isotype control (RTK2758; BioLegend) at 5 µg/ml.
For εGLT detection, 100,000 naive B cells (IgD+ CD19+ cells)
were incubated with recombinant IL-4 and IL-13 together with
SEB with or without TFH or CD25+ TF cells for 24–25 h. RNA was
extracted using phenol/chloroform extraction, and cDNA was
synthesized using SuperScript III (Invitrogen), according to the
manufacturer’s instructions. The following trancripts were
measured via qPCR and analyzed using the ΔΔCTmethod. εGLTs
were detected using the following primers (forward: 59-TGCATC
CACAGGCACCAAAT-39, reverse: 59-ATCACCGGCTCCGGGAAG
TA-3) and normalized to RPL13A expression levels (forward: 59-
CTCAAGGTGTTTGACGGCATCC-39, reverse: 59-TACTTCCAGCCA
ACCTCGTGAG-39). γGLTs weremeasured by using the following
primers (forward: 59-TCCAAGCCAACAGGGCAGGACACACCC
AGAG-39, reverse: 59-AAGTAGTCCTTGACCAGGCAG-39).
Human T reg cell suppression assays
10,000 CTV-labeled FACS-purified responder T cells (CD4+ CD3+
CD25−) were cocultured in the presence or absence of serially
diluted follicular or nonfollicular T reg cells starting with
20,000 cells. Cells were stimulated with αCD3/αCD28 mi-
crobeads (Miltenyi) at a 1:1 ratio of beads to T responder cells.
After 3 d, cells were stained with 7-aminoactinomycin D and
then analyzed by flow cytometry.
RNA-seq and analysis
The different subsets of human TF cells were FACS-purified
from three fresh tonsils. mRNA was extracted and sent to the
Australian Cancer Research Foundation Biomolecular Resource
Facility, The John Curtin School of Medical Research, The Aus-
tralian National University (ANU; Canberra, Australia), for li-
brary construction using the TruSeq Stranded mRNA LT Sample
Prep Kit (Illumina). Library samples were sequenced on a Hi-
Seq2000 machine with a coverage of 25 million reads. The data
were then sent to the Genome Discovery Unit (ANU Bio-
informatics Consulting Unit) for analysis. Initial quality control
checks with FastQC revealed that none of the 12 samples were
problematic. All reads were aligned to the Homo sapiens genome
reference sequence using TopHat version 2.0.13 with default
parameters. Read counts were then generated for each gene in
each sample using featureCounts version 1.4.6-p1 by using an-
notated gene locations. Differential expression analysis was
performed using the edgeR package, version 3.10. Read counts
per gene were normalized by trimmed mean of M-values. Be-
cause edgeR uses the negative binomial distribution as its basic
model for differential expression data, dispersion estimates
were obtained using the quantile-adjusted conditional maxi-
mum likelihoodmethod for single-factor experiments. Then, the
quantile-adjusted conditional maximum likelihood–based exact
test for the negative binomial distribution was performed to test
for differentially expressed genes in our groups of samples. We
used a Benjamini–Hochberg adjusted P value threshold of 0.05
to identify significantly differentially regulated genes. Data are
deposited under National Center for Biotechnology Information
Sequence Read Archive accession no. SRP072739.
Statistical analyses
All data were analyzed with nonparametric Mann–Whitney U
test, except for some human cell culture experiments, in which
paired Student’s t tests or two-way ANOVAs were used. Paired
analyses were performed using the Wilcoxon test. All statistical
analyses were performed with Prism software (version 6,
GraphPad). Statistically significant differences are indicated as
*, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001; ****, P ≤ 0.0001; and ns, not
significant.
Online supplemental material
Fig. S1 shows the frequency of CD25+ cells in human lymph node
tissue. Fig. S2 shows IL-21 production by the different TF cell
subsets. Fig. S3 compares T reg cell– and TFH cell–associated
protein expression among CD25+ TF cells and the more classical
FOXP3+ TFR cells. Fig. S4 shows that CD25+ TF-mediated re-
pression of TFH cells is IL-10 independent, as well as repression
of εGLTs in IgG+ and IgM+memory B cells. Fig. S5 shows Pearson
correlation analyses between the frequency of CD25+ TF cells in
tonsil versus IgG4 serum titers.
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